当前位置: X-MOL 学术Depression Anxiety › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations.
Depression and Anxiety ( IF 4.7 ) Pub Date : 2020-05-17 , DOI: 10.1002/da.23038
A Irem Sonmez 1 , Ammar Almorsy 1 , Laura B Ramsey 2 , Jeffrey R Strawn 3 , Paul E Croarkin 1
Affiliation  

Pediatric anxiety disorders such as generalized anxiety disorder (GAD) are common, impairing, and often undertreated. Moreover, many youth do not respond to standard, evidence‐based psychosocial or psychopharmacologic treatment. An increased understanding of the gamma‐aminobutyric acid (GABA) and glutamate neurotransmitter systems has created opportunities for novel intervention development for pediatric GAD.

中文翻译:


广泛性焦虑症的新药理学治疗:儿科考虑。



广泛性焦虑症(GAD)等小儿焦虑症很常见,会造成损害,而且往往治疗不足。此外,许多青少年对标准的、循证的心理社会或精神药物治疗没有反应。对 γ-氨基丁酸 (GABA) 和谷氨酸神经递质系统的深入了解为儿童广泛性焦虑症的新型干预开发创造了机会。
更新日期:2020-05-17
down
wechat
bug